The specter of RFK Jr. has investors fretting about a onetime vaccine wunderkind
In the chaotic early days of the pandemic, Wall Street scrambled to place bets on the companies that looked the most likely ...
Novavax Inc. stock outperforms competitors on strong trading day
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Novavax Advances Corporate Growth Strategy Through Sanofi Partnership, Including Achievement of First $50 Million Milestone
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced ...
Novavax advances growth strategy through partnership with Sanofi
Novavax (NVAX) announced progress in Q4 advancing its corporate growth strategy through its partnership with Sanofi (SNY). The company has ...
bovnews10h
The Novavax Inc Stock Thriller: Decoding the Mystery Behind NVAX’s Recent Movements
Novavax Inc (NVAX) stock saw a modest uptick, ending the day at $9.02 which represents a slight increase of $0.20 or 2.27% from the prior close of $8.82. The stock opened at $8.77 and touched a low of ...
Why Is Novavax (NVAX) Up 13.6% Since Last Earnings Report?
Novavax (NVAX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Stocktwits on MSN8h
Novavax Nabs $50M From First Sanofi Partnership Milestone: Retail Optimism Climbs
Shares of Novavax rose nearly 1% after the open on Friday, continuing a positive streak with gains expected for the third ...
Novavax Inc. stock underperforms Tuesday when compared to competitors
Shares of Novavax Inc. NVAX slid 3.31% to $8.77 Tuesday, on what proved to be an all-around poor trading session for the ...
Novavax begins dosing in COVID-19-influence and season influenza Phase 3 trial
Novavax (NVAX) announced that the first participants have been dosed in its COVID-19-Influenza Combination and stand-alone seasonal influenza ...
Jim Cramer Is 'Not A Fan' Of Novavax, Says This Tech Stock Is 'Expensive'
On CNBC's “ Mad Money Lightning Round ,” Jim Cramer said he is ‘not a fan' of Novavax, Inc. NVAX. On Dec. 4, Novavax agreed ...
bovnews2d
What’s Fueling Novavax Inc (NVAX) Stock’s -15.42% Loss Below Its 200-Day SMA?
On Tuesday, Novavax Inc (NVAX) stock saw a decline, ending the day at $8.77 which represents a decrease of $-0.30 or -3.31% from the prior close of $9.07. The stock opened at $9.1 and touched a low of ...
Cramer's Lightning Round: ‘I'm not a fan of Novavax'
Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...